BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21565241)

  • 1. Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu-Zn superoxide dismutase protein against Brucella abortus.
    Singha H; Mallick AI; Jana C; Fatima N; Owais M; Chaudhuri P
    Vaccine; 2011 Jun; 29(29-30):4720-7. PubMed ID: 21565241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2.
    González-Smith A; Vemulapalli R; Andrews E; Oñate A
    Immunobiology; 2006; 211(1-2):65-74. PubMed ID: 16446171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA; Donoso G; Moraga-Cid G; Folch H; Céspedes S; Andrews E
    Infect Immun; 2005 Jun; 73(6):3294-300. PubMed ID: 15908354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus.
    Singha H; Mallick AI; Jana C; Isore DP; Goswami TK; Srivastava SK; Azevedo VA; Chaudhuri P; Owais M
    Microbes Infect; 2008; 10(10-11):1089-96. PubMed ID: 18602490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
    Mallick AI; Singha H; Khan S; Anwar T; Ansari MA; Khalid R; Chaudhuri P; Owais M
    Vaccine; 2007 Nov; 25(46):7873-84. PubMed ID: 17931756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.
    Sáez D; Fernández P; Rivera A; Andrews E; Oñate A
    Vaccine; 2012 Feb; 30(7):1283-90. PubMed ID: 22222868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
    Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M
    Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide.
    Pakzad I; Rezaee A; Rasaee MJ; Hossieni AZ; Tabbaraee B; Kazemnejad A
    Roum Arch Microbiol Immunol; 2010; 69(1):5-12. PubMed ID: 21053778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.
    Goel D; Rajendran V; Ghosh PC; Bhatnagar R
    Vaccine; 2013 Feb; 31(8):1231-7. PubMed ID: 23273966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type.
    He Y; Vemulapalli R; Schurig GG
    Infect Immun; 2002 May; 70(5):2535-43. PubMed ID: 11953393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle.
    Sáez D; Guzmán I; Andrews E; Cabrera A; Oñate A
    Vet Microbiol; 2008 Jun; 129(3-4):396-403. PubMed ID: 18164561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.
    Surendran N; Sriranganathan N; Lawler H; Boyle SM; Hiltbold EM; Heid B; Zimmerman K; Witonsky SG
    Vaccine; 2011 Mar; 29(15):2749-55. PubMed ID: 21316499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544.
    Goel D; Bhatnagar R
    Mol Immunol; 2012 Jun; 51(2):159-68. PubMed ID: 22464098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice.
    Retamal-Díaz A; Riquelme-Neira R; Sáez D; Rivera A; Fernández P; Cabrera A; Guzmán CA; Oñate A
    Clin Vaccine Immunol; 2014 Nov; 21(11):1474-80. PubMed ID: 25165025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of recombinant B. abortus strain RB51SOD toward understanding the uncorrelated innate and adaptive immune responses induced by RB51SOD compared to its parent vaccine strain RB51.
    Zhu J; Larson CB; Ramaker MA; Quandt K; Wendte JM; Ku KP; Chen F; Jourdian GW; Vemulapalli R; Schurig GG; He Y
    Front Cell Infect Microbiol; 2011; 1():10. PubMed ID: 22919576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.